Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis

Biomarkers. 2017 Mar;22(2):127-132. doi: 10.1080/1354750X.2016.1252949. Epub 2016 Nov 7.

Abstract

Context: IGF-I serum levels are suppressed in cirrhosis, but its prognostic significance is unknown.

Objectives: To investigate the prognostic value of IGF-I in patients admitted for acute decompensation of cirrhosis.

Materials and methods: Cohort study that included 103 patients. IGF-I was measured by enzyme-linked immunosorbent assay (ELISA).

Results: Ninety-day mortality was 26.2% and it was independently associated with MELD, age and IGF-I. The Kaplan-Meier survival probability at 90 days was 94.3% in patients with IGF-I ≥13 ng/mL and 63.2% for patients with IGF-I <13 ng/mL (p = .001).

Discussion and conclusion: IGF-I levels are independently associated with mortality in acute decompensation of cirrhosis.

Keywords: IGF-I; Liver cirrhosis; ascites; portal hypertension.

MeSH terms

  • Aged
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Hypertension, Portal
  • Insulin-Like Growth Factor I / analysis*
  • Kaplan-Meier Estimate
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / mortality*
  • Middle Aged
  • Prognosis
  • Survival Analysis

Substances

  • Insulin-Like Growth Factor I